Welcome to BioMarket Group!

Johnson & Johnson: PharmaVitae Model 2009

Additional Information

Published Date Jan 27, 2009
Special Offer No
Pages No
PDF Fact Sheet No
Published on Date No
Format Interactive Model
Publisher Datamonitor
Product Line View All Available PharmaVitae Reports
Full Title No

Availability: In stock

$5,700.00

Quick Overview

This model contains historical and forecast sales data for Johnson & Johnson in the prescription pharmaceutical sector, based on company-reported, IMS and analyst consensus data.
Request free sample pages from Johnson & Johnson: PharmaVitae Model 2009

Introduction

This model contains historical and forecast sales data for Johnson & Johnson in the prescription pharmaceutical sector, based on company-reported, IMS and analyst consensus data. The model also presents the company’s R&D pipeline, historical financial data and product profiles.

Reasons to Purchase

  • Access key forecast product sales for Johnson & Johnson
  • View the company’s financial statements and pipeline data
Request free sample pages from Johnson & Johnson: PharmaVitae Model 2009

Other selected research from the 'PharmaVitae' category:


Organon: PharmaVitae Profile
This analysis examines the historical and forecast performance for Organon in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information. Learn More


PharmaVitae 2004: Chiron Global & US Analysis
This analysis examines the market position and future outlook for Chiron. The profile encompasses global and US specific company strategy, portfolio and pipeline analysis and assessment of financial performance, with US, rest of world and global forecasts for key drugs to 2010. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information Learn More

Other selected research from the 'Companies' category:


Carl Zeiss Meditec AG: Premium Company Profile
Carl Zeiss Meditec is an integrated medical technology company that develops, manufactures and markets diagnostic and therapeutic systems for the treatment of vision defects, cataracts, glaucoma and retinal disorders. The company operates in two main areas of business activity, namely: ophthalmology and neuro/ENT surgery. Learn More


Partnering Agreements with Novartis 2010
The Partnering Agreements with Novartis 2010 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.
This report provides all the information you require to better understand Novartis Labs and its partnering interests and activities over the past five years.
Learn More